| Market revenue in 2025 | USD 83.5 million |
| Market revenue in 2033 | USD 306.1 million |
| Growth rate | 17.6% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
| Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
The MEA market is expected to witness an increase in usage rates of biosimulation in the coming years. However, shortage of well-trained scientists in biology and computers is expected to slow down the growth in the present scenario.
Similarly, biologists with expertise in statistics, mathematical modeling, machine learning, artificial intelligence, software engineering, and/or database designing are also high in demand, thus creating a supply demand gap and urgency to promote biosimulation.
Publish Date: May 29, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Certara Inc Ordinary Shares | View profile | 1,391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | www.certara.com |
| Dassault Systemes SE | View profile | 23,811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | www.3ds.com |
| Avantium NV | View profile | 249 | Zekeringstraat 29-31, Amsterdam, Netherlands, 1014 BV | www.avantium.com |
| Simulations Plus Inc | View profile | 197 | 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059 | www.simulations-plus.com |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | www.schrodinger.com |
| Chemical Computing Group | View profile | 11-50 | Montreal, Quebec, Canada, North America | www.chemcomp.com |
| Physiomics | View profile | 11-50 | Oxford, Oxfordshire, United Kingdom, Europe | www.physiomics-plc.com/ |
| Rosa & Co | View profile | 11-50 | San Carlos, California, United States, North America | www.rosaandco.com |
| Genedata AG | View profile | 51-100 | Basel, Basel-Stadt, Switzerland, Europe | www.genedata.com/ |
| Instem | View profile | 51-100 | Conshohocken, Pennsylvania, United States, North America | www.instem.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biosimulation Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 71.14% in 2025.
Horizon Databook has segmented the Middle East & Africa biosimulation market based on software, services covering the revenue growth of each sub-segment from 2021 to 2033.
The MEA market is expected to witness an increase in usage rates of biosimulation in the coming years. However, shortage of well-trained scientists in biology and computers is expected to slow down the growth in the present scenario.
Similarly, biologists with expertise in statistics, mathematical modeling, machine learning, artificial intelligence, software engineering, and/or database designing are also high in demand, thus creating a supply demand gap and urgency to promote biosimulation.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Biosimulation Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Biosimulation Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.